[
  {
    "ts": null,
    "headline": "IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors",
    "summary": "IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=9a60f830b77f5fac3a581701b602d9b1d7f95ddda9e633a89460bba907ef888d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743785520,
      "headline": "IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors",
      "id": 133857767,
      "image": "",
      "related": "IDXX",
      "source": "MarketWatch",
      "summary": "IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=9a60f830b77f5fac3a581701b602d9b1d7f95ddda9e633a89460bba907ef888d"
    }
  },
  {
    "ts": null,
    "headline": "Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?",
    "summary": "Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
    "url": "https://finnhub.io/api/news?id=6f8fa51830ee1aeba5af6f09acc8686c2a3816cf7cb94839cd5faede0232e0b7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743783013,
      "headline": "Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?",
      "id": 133729404,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
      "url": "https://finnhub.io/api/news?id=6f8fa51830ee1aeba5af6f09acc8686c2a3816cf7cb94839cd5faede0232e0b7"
    }
  },
  {
    "ts": null,
    "headline": "Why Investors Need to Take Advantage of These 2 Medical Stocks Now",
    "summary": "Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.",
    "url": "https://finnhub.io/api/news?id=ecc8cab7645d7eea8eeb75ca603e5f99db7ec3aef5ac9baa4240df17ddd84dff",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743771609,
      "headline": "Why Investors Need to Take Advantage of These 2 Medical Stocks Now",
      "id": 133719772,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.",
      "url": "https://finnhub.io/api/news?id=ecc8cab7645d7eea8eeb75ca603e5f99db7ec3aef5ac9baa4240df17ddd84dff"
    }
  },
  {
    "ts": null,
    "headline": "Andvari Associates Q1 2025 Letter",
    "summary": "For Q1 2025, Andvari is up 7.2% net of fees while the SPDR S&P 500 ETF (SPY) is down 4.3%. Click here to read the full letter.",
    "url": "https://finnhub.io/api/news?id=61791deedff4c44e8e2d77783ef2274c21fb02347e8926a885f9e07dc64b7870",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743758700,
      "headline": "Andvari Associates Q1 2025 Letter",
      "id": 133704549,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/942696884/image_942696884.jpg?io=getty-c-w1536",
      "related": "IDXX",
      "source": "SeekingAlpha",
      "summary": "For Q1 2025, Andvari is up 7.2% net of fees while the SPDR S&P 500 ETF (SPY) is down 4.3%. Click here to read the full letter. ",
      "url": "https://finnhub.io/api/news?id=61791deedff4c44e8e2d77783ef2274c21fb02347e8926a885f9e07dc64b7870"
    }
  }
]